Pfizer’s antiviral pills appears effective against omicron variant, company says

Pfizer’s COVID-19 antiviral pill cuts the risk of hospitalization and death by nearly 90% among adults at high risk for severe illness, according to final data from the company’s clinical trial. Lab tests also suggest the experimental drug, named Paxlovid, is effective against the omicron variant.

Leave a Reply